Direct Oral Anticoagulant Levels at Time of Elective Surgery
JAMA Network Open · 04.02.2026 · 9 (2) · e2555875
DOI: 10.1001/jamanetworkopen.2025.55875 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 04.02.2026. Verfasst von Eleonora Camilleri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Elective Surgical Procedures, Blood Loss, Surgical, Anticoagulants, Factor Xa Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Before elective surgery, direct oral anticoagulants (DOACs) are discontinued following a standardized protocol. However, this could result in insufficient lowering of DOAC levels that could increase bleeding risk.
Objective
To estimate the proportion of patients with elevated DOAC levels at the time of elective surgery, evaluate factors associated with DOAC levels, and examine associated blood loss. Design, Setting, and Participants This cohort study (DOAC Level Prior to Incision [DALI]) assessed adult patients prescribed a DOAC (apixaban, dabigatran, or rivaroxaban) for any indication and at any dose, undergoing an elective procedure requiring DOAC interruption between May 27, 2018, and February 25, 2024, at 2 Dutch hospitals. Exposure Standardized interruption protocol (1 day before moderate- and 2 days before high bleeding-risk procedures) with interruption adjustments for the patient’s kidney function. Main Outcomes and Measures Blood was drawn immediately before surgery to determine DOAC levels (by liquid chromatography–mass spectrometry). Proportions of preoperative DOAC levels of 30 ng/mL or higher and their 95% CIs were estimated, stratified by DOAC type and surgical bleeding risk. Factors associated with DOAC levels were identified through multivariable linear regression. Surgical blood loss and 30-day postoperative complications were described according to DOAC concentrations.
Results
The study was terminated after including 257 patients (100 receiving apixaban, 100 receiving rivaroxaban, and 57 receiving dabigatran due to the slow inclusion rate of those receiving dabigatran; median [IQR] age, 72 [66-78] years; 173 male [67%]); 212 patients (82%) underwent a high bleeding-risk operation. Preprocedural DOAC levels were 30 ng/mL or higher in 7.6% (95% CI, 4.9%-11.6%) of patients. Dabigatran and rivaroxaban had similar proportions, whereas 13.1% (95% CI, 7.8%-21.2%) of patients treated with apixaban had levels of 30 ng/mL or higher. Treatment with apixaban, decreased kidney function, and a shorter interruption time were associated with higher levels. Surgical blood loss (median [range], 0 [0-4250] mL) was not associated with DOAC levels. Twelve patients (4.7%; 95% CI, 2.7%-8.0%), who all had DOAC levels less than 30 ng/mL, experienced major bleeding. Conclusions and Relevance In this cohort study, most patients following the current protocol had DOAC levels less than 30 ng/mL, although the proportion of patients with elevated levels was higher for apixaban. Preoperative DOAC levels were not associated with blood loss during surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Hospital Pharmacy, Haga Teaching Hospital, The Hague, the Netherlands.
- Department of Anesthesiology, Haga Hospital Juliana Children's Hospital, Den Haag, the Netherlands.
- Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, the Netherlands.
Zitieren
APA
Camilleri, E., Shahbabai, P., Rad, M., Huijzer, C. A., Huisman, M. V., van Dorp, E. L. A., Visser, L. E., Guchelaar, H. J., Cannegieter, S. C., & van Rein, N. (2026). Direct Oral Anticoagulant Levels at Time of Elective Surgery. JAMA Network Open, 9(2), e2555875. https://doi.org/10.1001/jamanetworkopen.2025.55875
Vancouver
Camilleri E, Shahbabai P, Rad M, Huijzer CA, Huisman MV, van Dorp ELA, et al. Direct Oral Anticoagulant Levels at Time of Elective Surgery. JAMA Network Open. 2026;9(2):e2555875. doi:10.1001/jamanetworkopen.2025.55875
BibTeX
@article{Camilleri2026,
author = {Camilleri, Eleonora and Shahbabai, Payam and Rad, Mandana and Huijzer, Charlotte A and Huisman, Menno V and van Dorp, Eveline L A and Visser, Loes E and Guchelaar, Henk-Jan and Cannegieter, Suzanne C and van Rein, Nienke},
title = {Direct Oral Anticoagulant Levels at Time of Elective Surgery},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {2},
pages = {e2555875},
doi = {10.1001/jamanetworkopen.2025.55875}
}
EUVIMED